Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...
A doctor from the University of Palermo in Italy has published a case study of an adult cocaine user who experienced reduced withdrawal symptoms when given GLP-1 therapy. In the case study published ...
The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...
2h
24/7 Wall St. on MSNHims & Hers (HIMS) Down 21% – Is the GLP-1 Gravy Train Over?Shares of Hims & Hers Health (NYSE:HIMS) are down about 21%, or $14. All on news the Ozempic shortage is over. Key Points ...
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic anterior optic neuropathy (NAION).
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
A bipartisan group of U.S. state and territory attorneys general is pressing the FDA to take prompt action against those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results